Related Experiment Video
Updated: Aug 19, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
D2-blockade and possible ziprasidone-induced galactorrhea
Mohamed Ramadan1, Ahsan Khan, Sheldon Preskorn
1Department of Psychiatry, School of Medicine, University of Kansas, Wichita, KS 67214, USA. ibramadan@yahoo.com
Abstract:
This is the second report of possible ziprasidone-induced galactorrhea in an adult female. This case illustrates the need to consider dose as well as potency when interpreting the response of a patient to a drug, particularly when the response appears to be idiosyncratic.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Dipeptidyl Peptidase 4 Inhibitors
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antipsychotic Drugs: Typical and Atypical Agents
Depolarizing Blockers: Pharmocokinetics
